Author

Heidi N. Beadnall

Observed names: Beadnall, H, Beadnall, Heidi, Beadnall, Heidi N, H N Beadnall, H.N. Beadnall, Heidi Beadnall, Heidi N Beadnall

Institutions: The University of Sydney, Royal Prince Alfred Hospital

Observed institutions: Griffith University, The University of Sydney, Royal Prince Alfred Hospital, Concord Repatriation General Hospital, Children's Hospital at Westmead, John Radcliffe Hospital, Westmead Hospital, University of Oxford, St Vincent's Hospital Sydney, St George Hospital, Oxford University Hospitals NHS Trust

ORCID: 0000-0003-3734-4133

Observed ORCID: 0000-0003-3734-4133

OpenAlex ID: A5066388127

Exosomal microRNA signatures in multiple sclerosis reflect disease status

2017 · Saeideh Ebrahimkhani, Fatemeh Vafaee, et al. · Scientific Reports · 262

PDF

Deep sequencing of circulating exosomal microRNA allows non-invasive glioblastoma diagnosis

2018 · Saeideh Ebrahimkhani, Fatemeh Vafaee, et al. · npj Precision Oncology · 153

PDF

Overlapping central and peripheral nervous system syndromes in MOG antibody–associated disorders

2020 · Simon Rinaldi, Alexander Davies, et al. · Neurology Neuroimmunology & Neuroinflammation · 102

PDF

Serum Exosome MicroRNAs Predict Multiple Sclerosis Disease Activity after Fingolimod Treatment

2019 · Saeideh Ebrahimkhani, Heidi N. Beadnall, et al. · Molecular Neurobiology · 69

The evolution of “No Evidence of Disease Activity” in multiple sclerosis

2017 · G. Lu, H.N. Beadnall, et al. · Multiple Sclerosis and Related Disorders · 63

A real-world clinical validation for AI-based MRI monitoring in multiple sclerosis

2023 · Michael Barnett, Dongang Wang, et al. · npj Digital Medicine · 56

PDF

Automated brain volumetrics in multiple sclerosis: a step closer to clinical application

2016 · C Wang, H N Beadnall, et al. · Journal of Neurology Neurosurgery & Psychiatry · 49

PDF

Diagnosis, differential diagnosis and misdiagnosis of Susac syndrome

2022 · James D. Triplett, Jessica Qiu, et al. · European Journal of Neurology · 41

PDF

Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial

2020 · Jacqueline Palace, Dean M. Wingerchuk, et al. · Multiple Sclerosis and Related Disorders · 41

PDF

Comparing longitudinal brain atrophy measurement techniques in a real-world multiple sclerosis clinical practice cohort: towards clinical integration?

2019 · H.N. Beadnall, C. Wang, et al. · Therapeutic Advances in Neurological Disorders · 31

PDF

Baló's concentric sclerosis and tumefactive demyelination: A shared immunopathogenesis?

2014 · Todd A. Hardy, Heidi N. Beadnall, et al. · Journal of the Neurological Sciences · 23

A randomized controlled trial of a web-based mindfulness programme for people with MS with and without a history of recurrent depression

2022 · Amy-Lee Sesel, Louise Sharpe, et al. · Multiple Sclerosis Journal · 22

The neuro-otology of Susac syndrome

2020 · Todd A. Hardy, Rachael L. Taylor, et al. · Journal of Neurology · 22

Investigation of tumefactive demyelination is associated with higher economic burden and more adverse events compared with conventional multiple sclerosis

2019 · Matthew Silsby, Pedro Sánchez, et al. · Multiple Sclerosis and Related Disorders · 15

The evaluation of an online mindfulness program for people with multiple sclerosis: study protocol

2019 · Amy-Lee Sesel, Louise Sharpe, et al. · BMC Neurology · 14

PDF

Multiple sclerosis: structural and functional integrity of the visual system following alemtuzumab therapy

2021 · Chenyu Wang, Joshua Barton, et al. · Journal of Neurology Neurosurgery & Psychiatry · 13

PDF

Development of a Web-Based Mindfulness Program for People With Multiple Sclerosis: Qualitative Co-Design Study

2020 · Amy-Lee Sesel, Louise Sharpe, et al. · Journal of Medical Internet Research · 12

PDF

Precision therapy for neuromyelitis optica spectrum disorder: A retrospective analysis of the use of class-switched memory B-cells for individualised rituximab dosing schedules

2020 · Benjamin P. Trewin, Stephen Adelstein, et al. · Multiple Sclerosis and Related Disorders · 12

2016 · Heidi N. Beadnall, Anthony J. Gill, et al. · Neurology · 11

Tablet‐based screening improves continence management in multiple sclerosis

2015 · Heidi N. Beadnall, Kushi E. Kuppanda, et al. · Annals of Clinical and Translational Neurology · 11

PDF

Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 2

2025 · Jessica Shipley, James Beharry, et al. · The Medical Journal of Australia · 10

Successful implementation of an automated electronic support system for patient safety monitoring: The alemtuzumab in multiple sclerosis safety systems (AMS3) study

2018 · Stephen W Reddel, Michael H Barnett, et al. · Multiple Sclerosis Journal · 10

Treatment satisfaction in patients with relapsing-remitting multiple sclerosis initiated on teriflunomide in routine clinical practice: Australian observational data

2022 · Todd A Hardy, John Parratt, et al. · BMJ Neurology Open · 9

PDF

Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 1

2025 · Jessica Shipley, James Beharry, et al. · The Medical Journal of Australia · 8

2025 · Jessica Shipley, Heidi N. Beadnall, et al. · JAMA Network Open · 5

PDF

Works count: 85

Citation count: 1,094

H-index: 14

I10-index: 22